We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
DO NOT use the Eversense® Apps on jailbroken or rooted devices.
Jailbroken devices do not provide an acceptable level of security and accuracy for the user, and are not approved for use by Senseonics
You will need to install the app on your new mobile device and pair it with your smart transmitter. The
last 3 days of glucose data will be synced to the app on the new mobile device.
Certain app store requirements require mobile apps to provide users with the ability to initiate account deletion.
If you already have an Eversense® account, you do not have to create a new one to use Eversense® NOW.
If you DO NOT already have an Eversense® account
Choose the unit of measure. The unit of measure you choose will apply to all of the Eversense® CGM users whose data you can view. You cannot change the unit of measure once the app is installed unless you delete and reinstall the app.
The Eversense NOW App will periodically check to confirm your log in information has not been changed via your Eversense DMS account.
If you change your Eversense account password from your DMS log in screen or the DMS Change Password page, you must log out of the Eversense NOW App and log back in using the new password. If the passwords do not match functionality of the Eversense NOW app will be unavailable.
While it is possible, in the Eversense E3 pivotal clinical trial (PROMISE Study), most users were in 1 calibration/day 62% of the time and in 2 calibrations a day 38% of the time, after day 21.
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0060